Browsing by Author "Ruiz Argüelles, Guillermo J."

Now showing items 1-2 of 2

    • All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic ... 
      Sanz, Miguel A.; Montesinos, Pau; Kim, Haesook T.; Ruiz Argüelles, Guillermo J.; Undurraga, María; Uriarte, María R.; Martínez, Lem; Jacomo, Rafael H.; Gutiérrez Aguirre, Homero; Melo, Raúl; Bittencourt, Rosane; Pasquini, Ricardo; Pagnano, Katia; Fagundes, Evandro M.; Vellenga, Edo; Holowiecka, Alexandra; González Huerta, Ana J.; Fernández, Pascual; Serna, Javier de la; Brunet, Salut; Lisa, Elena de; González Campos, José; Ribera, José M.; Krsnik, Isabel; Ganser, Arnold; Berliner, Nancy; Ribeiro, Raul C.; Lo-Coco, Francesco; Löwenberg, Bob; Rego, Eduardo M. (Springer, 2015)
      Front-line treatment of acute promyelocytic leukaemia (APL) consists of all-trans retinoic acid (ATRA) and anthracycline-based chemotherapy. In this setting, a comparison of idarubicin and daunorubicin has never been carried ...
    • Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients ... 
      Hungría, Vania T. M.; Lee, Jae Hoon; Maiolino, Angelo; de Queiroz Crusoe, Edvan; Martínez, Gracia; Bittencourt, Rosane; Oliveira Duarte, Gislaine; Fantl, Dorotea Beatriz; Navarro, Juan Ramón; Conte, Guillermo; Gómez Almaguer, David; Ruiz Argüelles, Guillermo J.; Kim, Kihyun; Shimizu, Kazuyuki; Chen, Wenming; Shang, Shang-YI; Chng, Wee-Joo; Chim, Chor Sang; Nawarawong, Weerasak; Durie, Brian (Springer, 2019)
      In previous observational studies, we have separately characterized patients with multiple myeloma (MM) both from Latin America (LA) and from Asia. Here, we analyze these two datasets jointly, in order to assess the overall ...